Neosphere Biotechnologies and Kymera Therapeutics partner to advance molecular glue target discovery
Neosphere Biotechnologies GmbH has entered into a collaboration with Kymera Therapeutics Inc. that seeks to unlock undrugged or poorly drugged disease-causing protein targets that can be addressed by ...
The Institute of Cancer Research and biotechnology company NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of molecular glue degrader drugs. The collaboration ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback